Danaher Co. (NYSE:DHR) Shares Bought by Jordan Park Group LLC

Jordan Park Group LLC grew its stake in shares of Danaher Co. (NYSE:DHR) by 17.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,129 shares of the conglomerate’s stock after acquiring an additional 170 shares during the period. Jordan Park Group LLC’s holdings in Danaher were worth $259,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. AMF Tjanstepension AB purchased a new stake in shares of Danaher in the third quarter valued at $5,923,000. Howard Capital Management Group LLC lifted its holdings in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 48 shares in the last quarter. Foundations Investment Advisors LLC lifted its holdings in shares of Danaher by 5.3% in the third quarter. Foundations Investment Advisors LLC now owns 1,637 shares of the conglomerate’s stock valued at $455,000 after purchasing an additional 82 shares in the last quarter. Oakworth Capital Inc. lifted its holdings in shares of Danaher by 14.2% in the third quarter. Oakworth Capital Inc. now owns 523 shares of the conglomerate’s stock valued at $145,000 after purchasing an additional 65 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its holdings in shares of Danaher by 7.9% in the third quarter. Sequoia Financial Advisors LLC now owns 20,803 shares of the conglomerate’s stock valued at $5,784,000 after purchasing an additional 1,527 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.3 %

DHR stock opened at $205.23 on Thursday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a 50-day moving average of $227.74 and a two-hundred day moving average of $247.80. The stock has a market capitalization of $148.24 billion, a price-to-earnings ratio of 38.87, a price-to-earnings-growth ratio of 2.63 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. As a group, equities research analysts anticipate that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.45%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 10.90% of the company’s stock.

Analysts Set New Price Targets

DHR has been the subject of a number of research analyst reports. Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price for the company. Stephens reaffirmed an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research note on Friday, December 13th. Citigroup dropped their price target on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.